← Back
$DTIL All transactions

PRECISION BIOSCIENCES INC

▼ SELL 10b5-1 Plan

$ Value

$22K

Shares

3,409

Price

$6

Filed

Nov 4

Insider

Name

Amoroso Michael

Title

President and CEO

CIK

0001830874

Roles

Director Officer

Transaction Details

Transaction Date

2025-11-03

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

115,575

Footnotes

Represents the vesting and settlement of Restricted Stock Units ("RSUs") on November 2, 2025. | Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. | The sales were effected pursuant to a Rule 10b5-1 plan adopted on August 2, 2024. The transaction was a sell-to-cover, with shares only sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees. | On November 2, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on November 2, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. The RSUs vested in full on November 2, 2025.

Filing Info

Accession No.

0001628280-25-048855

Form Type

4

Issuer CIK

0001357874

Amoroso Michael's History

Date Ticker Type Value
2026-02-18 DTIL $79K
2026-02-17 DTIL M $0
2026-02-17 DTIL M $0
2026-01-26 ABEO A $0
2026-01-22 DTIL $145K
2026-01-20 DTIL M
2026-01-20 DTIL M
2026-01-20 DTIL M
2026-01-20 DTIL M $0
2026-01-20 DTIL M $0

Other Insiders at DTIL (90d)

Insider Bought Sold Last
Kelly John Alexander
Chief Financial Officer
$31K 2026-02-18
SMITH J. JEFFERSON
Chief Research Officer
$19K 2026-02-18
Scimeca Dario
General Counsel and Secretary
$19K 2026-02-18
Amoroso Michael
President and CEO
$79K 2026-02-18